There is no over-the-counter GLP-1 drug
Scientists studying these drugs have reported improvements in cardiovascular disease, liver disease, migraines, sleep apnea and more
How Rybelsus Works and Potential Drug Interactions Rybelsus contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for the treatment of type 2 diabetes mellitus
The drug officially hit the market in December
Global News reports that this is the first GLP1 pill approved in Canada and that all other GLP1 therapies available in the country to date are injectables
Begin Your Journey Now Opening a semaglutide weight loss chapter through Klinic in Allen Park, Michigan, streamlines access to personalized, insurance-backed care with our expert team of independent healthcare providers